Overall Status

Completed (26)

Recruiting (11)

Terminated (7)

Active, not recruiting (4)

Not yet recruiting (2)

Unknown status (2)

Withdrawn (1)

Phase

phase 2 (18)

phase 1 (8)

n/a (6)

phase 3 (5)

early phase 1 (2)

phase 1/phase 2 (2)

phase 2/phase 3 (1)

Study Documents

Intervention Type

drug (30)

biological (9)

procedure (7)

device (5)

other (3)

radiation (2)

Funder Type

Other (46)

Industry (5)

NIH (2)

Study Type

Interventional (42)

Observational (9)

Observational [Patient Registry] (2)

myelodysplasia

Showing 51 - 53 of 53

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus

Completed

Hematological Malignancy
+5 more

Alcalá de Henares, Spain
+11 more

Nov 13, 2009

Hematological Malignancies, Myelodysplasia, Agnogenic Myeloid Metaplasia Trial in Toronto (MKC-1)

Completed

Hematological Malignancies
+2 more

MKC-1

Toronto, Canada

Princess Margaret Hospital

May 4, 2009

Chronic Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplasia Trial in San Francisco (Busulfan/Fludarabine

Completed

Chronic Myeloid Leukemia
+8 more

Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF

San Francisco, California

University of California San Francisco

Jan 22, 2009